In 2016, more than 42,000 people in the United States died from opioid overdoses. A host of complex social, structural and drug-related factors have contributed to the overdose epidemic, but one of the primary factors in recent years is the synthetic opioid fentanyl. Officials are focused on a variety of efforts to address the opioid epidemic and overdose crisis, including finding solutions to help prevent new addictions, increasing access to treatment, trying to halt the supply of illicit substances. But to a far lesser extent, they include harm reduction – or strategies aimed at protecting the health and saving the lives of those people who are actively using drugs. In this episode, we talk about harm reduction, and we take a look at a recent study that has the potential to inform an innovative public health approach to the overdose epidemic.
Bloomberg Fellows Spotlight: Lydia Watts
Bloomberg Fellows Spotlight: Natalie J. Tunzi
Bloomberg Fellows Spotlight: Julianah Marie
Bloomberg Fellows Spotlight: Emily Foxman
Racial Injustice, COVID-19, and Youth
Massachusetts’ Unique Approach to COVID-19 Vaccine Rollouts
Are States Ready for Climate Change?
The Social Context of Intimate Partner Violence
Re-Imagining Policing for the Public Health
Seeking change agents: The Bloomberg Fellows Program
Building Resilience in Puerto Rico
The Coronavirus Crisis: How COVID-19 is Impacting Sex Workers and People Who Use Drugs
The Coronavirus Crisis: Keeping Youth Connected
The Coronavirus Crisis: The Impact on Gun Violence
Rolling Back a Landmark Environmental Law
Where Do Criminals Get their Guns?
The Voice of Youth in Baltimore
Making Cities Safer, One Vacant Lot at a Time
Making Sense of Opioid Litigation
Preventing Suicide, Part 5: How Restricting Access to Guns Can Prevent Suicide
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Masters in Business
Odd Lots
Bloomberg Surveillance
Bloomberg Businessweek
Prognosis: Losing it